tmmonline.nz  |   landlords.co.nz        About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds

NZ's Financial Adviser News Centre

GR Logo
Last Article Uploaded: Monday, December 8th, 6:19PM

Insurance

rss
Latest Headlines

AMP life sales sluggish in Q4

AMP's life insurance business grew very sluggishly during the December quarter, despite it being the second largest player in the top three product categories.

Monday, March 21st 2011, 9:35AM 1 Comment

by Jenny Ruth

The largest player, Sovereign, held its own, while other companies, including Fidelity, Onepath and AIA grew particularly strongly in some product categories.

In force term term premiums, which account for 47% of the total industry, grew by $3.7 million to $236 million at Sovereign with its new business at $5.1 million for the three months ended December.

The much smaller Fidelity grew its in force term premiums almost as much by $3.7 million to $49.9 million as it attracted new business of nearly $2 million

By contrast, AMP, saw in force premiums grow just $0.9 million to $102.1 million as its new business was $0.9 million.

Half AMP's size, AIA's in force term policies grew three times as much, by $2.9 million to $52.7 million, in the three months while Onepath's grew by $2.5 million to $73.8 million.

Income replacement policies in force at Sovereign grew just over $1 million to $78.9 million as its new business was $1.7 million.

AMP's income replacement in force business grew $0.8 million to $25.8 million with new business at just $0.3 million.

Much faster growers in the category were Onepath, up $1.5 million to $25.1 million with new business of $2.1 million and Asteron, up $1.2 million to $24.8 million with new business at $0.9 million.

Apart from AXA, whose figures were distorted by reclassifications, Sovereign showed greatest growth in in force trauma policies, up $2.8 million to $82.7 million with new business at $3 million.

Onepath also grew strongly by $1.5 million to $21.8 million with new business of $2 million. AMP's growth in this product category was also sluggish at $0.7 million to $25.2 million and its new business just $0.3 million.

In the fourth largest product category, traditional whole life and endowment, in which AMP is the dominant player, most companies lost ground with little new business sold. AMP's in force policies fell $0.3 million to $52.1 million, AXA's fell $0.4 million to $32.7 million , Sovereign's fell $0.4 million to $18.1 million and Tower's fell $0.3 million to $11.4 million.

« December life insurance sales flatlineMixed reviews from advisers on FMA regulation »

Special Offers

Comments from our readers

On 21 March 2011 at 2:23 pm Alastar said:
No real surprise to read here that AMP is struggling with its in force premiums. With Partners Life about to emerge on the scene AMP’s share of the life insurance market will only get less and less again over time. Institutional arrogance is AMP’s single biggest handicap to it writing new business. Unless Regan wakes up to this fact then he’ll find he’s at the helm of a sinking ship.
Commenting is closed

 

print

Printable version  

print

Email to a friend
Insurance Briefs

Partners Life hikes premiums again
Partners Life is lifting the cost of its Private Medical Cover again, with premiums set to rise to 23% for existing business with policy anniversaries on or after 22 October 2025.

Insurtech company wins FSC Innovation of the Year Award
Insurtech company aiming to clean up life insurance legacy systems wins innovation award.

UniMed offers support to members with cancer
UniMed partners with Osara Health to provide enhanced cancer support

Chubb Life CEO wraps up three-month adviser tour
Chubb Life NZ CEO Paula ter Brake has wrapped up the Midwinter Connect series, where she met with over 800 advisers across 11 locations. The three-month nationwide tour began 24 days into her new role.

News Bites
Latest Comments
Subscribe Now

Cover Notes - Specific news aimed at risk advisers

Previous News

MORE NEWS»

Most Commented On
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox  |  Disclaimer
 
Site by Web Developer and eyelovedesign.com
x